TrialPLoS medicine2021

Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.

Jonathon W Senefeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.